Notice: Prescription Drug List (PDL): Triamcinolone acetonide

Notice: Prescription Drug List (PDL): Triamcinolone acetonide The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt Triamcinolone acetonide. 2023-09-30 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetynotice of amendmentPrescription Drug ListPDLTriamcinolone acetonide Notice: Prescription Drug List (PDL): Triamcinolone acetonideHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-triamcinolone-acetonide-2.html Notice: Prescription Drug List (PDL): Triamcinolone acetonideHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-liste-acetonide-triamcinole-2.html

The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt Triamcinolone acetonide.

Data and Resources

Similar records